Cancer Stem Cell Trends
WEST HARTFORD, Conn., April 16, 2014 /PRNewswire-iReach/ -- Global Information Inc. announces the addition of a new market research report "Cancer Stem Cell Trends" at GIIResearch.com
The report illustrates on the growing market for Cancer Stem Cells (CSCs) in the US and Europe The major factors stimulating the growth of the market are the rising affliction of diseases such as cancer and the reimbursement assistance by regulatory organizations in developed nations including the US and Europe. Cancer Stem Cells (CSCs) are the cells within a tumor that possess the capability of self-renewal and driving tumorigenesis. In the previous research studies, rare CSCSs have been isolated from several human tumors such as brain, breast, colon and haematopoietic cancers. CSCs are believed to survive in tumors as a completely distinct population and might cause metastasis and relapse by producing new tumors. In addition, the report highlights the exponential rise in research on Cancer Stem Cells (CSCs), and the design of novel drugs to treat CSCs. Major players in the field include Boston Biomedical Inc., Macrogenics, and Verastem, Inc.
Table of Contents
- CANCER STEM CELLS - A FOCUS REPORT
- TECHNOLOGY OVERVIEW
- MARKET INFORMATION
- NOTEWORTHY MARKET PARTICIPANTS
- CORPORATE/RESEARCH INITIATIVES
More detailed information is available at
Media Contact: Joe Malley, Global Information, Inc., 860-674-8796, USemail@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Global Information, Inc.